Absci Corporation
General ticker "ABSI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $491.2M (TTM average)
Absci Corporation follows the US Stock Market performance with the rate: 54.6%.
Estimated limits based on current volatility of 5.4%: low 8.26$, high 9.21$
Factors to consider:
- Total employees count: 140 (-10.8%) as of 2025
- Top business risk factors: Technology failures, Strategic risks and growth management, Key person loss, Operational and conduct risks, Facility damage
- Current price 54.4% above estimated high
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.22$, 5.38$]
- 2026-12-31 to 2027-12-31 estimated range: [2.24$, 5.38$]
Financial Metrics affecting the ABSI estimates:
- Positive: with PPE of -4.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 87.59 > 64.23
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0.04 <= 0.74
- Positive: Inventory ratio change, % of -1.13 <= -0.75
Short-term ABSI quotes
Long-term ABSI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $5.72MM | $4.53MM | $2.80MM |
| Operating Expenses | $121.23MM | $113.42MM | $123.12MM |
| Operating Income | $-115.52MM | $-108.89MM | $-120.32MM |
| Non-Operating Income | $5.05MM | $5.85MM | $5.20MM |
| Interest Expense | $1.01MM | $0.56MM | $0.21MM |
| R&D Expense | $48.07MM | $63.86MM | $81.42MM |
| Income(Loss) | $-110.47MM | $-103.04MM | $-115.11MM |
| Taxes | $0.10MM | $0.07MM | $0.07MM |
| Net Income(Loss)* | $-110.57MM | $-103.11MM | $-115.18MM |
| Stockholders Equity | $176.18MM | $179.13MM | $189.45MM |
| Assets | $217.30MM | $213.61MM | $216.30MM |
| Operating Cash Flow | $-64.64MM | $-72.40MM | $-92.92MM |
| Capital expenditure | $0.86MM | $0.40MM | $1.11MM |
| Investing Cash Flow | $81.94MM | $-41.58MM | $-50.16MM |
| Financing Cash Flow | $-4.48MM | $82.53MM | $105.95MM |
| Earnings Per Share** | $-1.20 | $-0.94 | $-0.84 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.